226 related articles for article (PubMed ID: 34726230)
1. Application of the Athlete Biological Passport Approach to the Detection of Growth Hormone Doping.
Equey T; Pastor A; de la Torre Fornell R; Thomas A; Giraud S; Thevis M; Kuuranne T; Baume N; Barroso O; Aikin R
J Clin Endocrinol Metab; 2022 Feb; 107(3):649-659. PubMed ID: 34726230
[TBL] [Abstract][Full Text] [Related]
2. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score.
Erotokritou-Mulligan I; Eryl Bassett E; Cowan DA; Bartlett C; Milward P; Sartorio A; Sönksen PH; Holt RI
Clin Endocrinol (Oxf); 2010 Apr; 72(4):520-6. PubMed ID: 19650783
[TBL] [Abstract][Full Text] [Related]
3. Potential parameters for the detection of hGH doping.
Kniess A; Ziegler E; Kratzsch J; Thieme D; Müller RK
Anal Bioanal Chem; 2003 Jul; 376(5):696-700. PubMed ID: 12750868
[TBL] [Abstract][Full Text] [Related]
4. Tracking growth hormone abuse in sport: performance of marker proteins in a controlled setting.
Bosch J; Such-Sanmartín G; Segura J; Gutiérrez-Gallego R
Anal Chim Acta; 2012 Oct; 745():118-23. PubMed ID: 22938615
[TBL] [Abstract][Full Text] [Related]
5. The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
Holt RI; Böhning W; Guha N; Bartlett C; Cowan DA; Giraud S; Bassett EE; Sönksen PH; Böhning D
Drug Test Anal; 2015 Sep; 7(9):745-55. PubMed ID: 25645199
[TBL] [Abstract][Full Text] [Related]
6. Procollagen type III amino-terminal propeptide and insulin-like growth factor I as biomarkers of growth hormone administration.
Cowan DA; Moncrieffe DA
Drug Test Anal; 2022 May; 14(5):808-819. PubMed ID: 34418311
[TBL] [Abstract][Full Text] [Related]
7. Intra-individual variation of GH-dependent markers in athletes: comparison of population based and individual thresholds for detection of GH abuse in sports.
Kniess A; Ziegler E; Thieme D; Müller RK
J Pharm Biomed Anal; 2013 Oct; 84():201-8. PubMed ID: 23850935
[TBL] [Abstract][Full Text] [Related]
8. The intra-individual stability of GH biomarkers IGF-I and P-III-NP in relation to GHRH administration, menstrual cycle, and hematological parameters.
Ericsson M; Bhuiyan H; Yousif B; Lehtihet M; Ekström L
Drug Test Anal; 2020 Nov; 12(11-12):1620-1628. PubMed ID: 33125822
[TBL] [Abstract][Full Text] [Related]
9. Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex.
Guha N; Erotokritou-Mulligan I; Bartlett C; Nevitt SP; Francis M; Bassett EE; Cowan DA; Sönksen PH; Holt RI
J Clin Endocrinol Metab; 2014 Jun; 99(6):2259-68. PubMed ID: 24606087
[TBL] [Abstract][Full Text] [Related]
10. Longitudinally monitoring of P-III-NP, IGF-I, and GH-2000 score increases the probability of detecting two weeks' administration of low-dose recombinant growth hormone compared to GH-2000 decision limit and GH isoform test and micro RNA markers.
Lehtihet M; Bhuiyan H; Dalby A; Ericsson M; Ekström L
Drug Test Anal; 2019 Mar; 11(3):411-421. PubMed ID: 30223291
[TBL] [Abstract][Full Text] [Related]
11. hGH isoform differential immunoassays applied to blood samples from athletes: decision limits for anti-doping testing.
Hanley JA; Saarela O; Stephens DA; Thalabard JC
Growth Horm IGF Res; 2014 Oct; 24(5):205-15. PubMed ID: 24973245
[TBL] [Abstract][Full Text] [Related]
12. The UK Sport perspective on detecting growth hormone abuse.
Stow MR; Wojek N; Marshall J
Growth Horm IGF Res; 2009 Aug; 19(4):375-7. PubMed ID: 19487144
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Profiling of Endogenous Steroids in Blood Using the Athlete Biological Passport Approach.
Equey T; Salamin O; Ponzetto F; Nicoli R; Kuuranne T; Saugy J; Saugy M; Aikin R; Baume N
J Clin Endocrinol Metab; 2023 Jul; 108(8):1937-1946. PubMed ID: 36794909
[TBL] [Abstract][Full Text] [Related]
14. Biomarker detection of rhGH doping: an excretion study.
Jing J; Zhou X; He C; Zhang L; Yang S; Xu Y; Xie M; Yan Y; Su H; Wu M
Drug Test Anal; 2012 Oct; 4(10):739-44. PubMed ID: 23074170
[TBL] [Abstract][Full Text] [Related]
15. The effect of a period of intense exercise on the marker approach to detect growth hormone doping in sports.
Voss SC; Robinson N; Alsayrafi M; Bourdon PC; Schumacher YO; Saugy M; Giraud S
Drug Test Anal; 2014 Jun; 6(6):582-6. PubMed ID: 24827554
[TBL] [Abstract][Full Text] [Related]
16. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
Vernec AR
Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
[TBL] [Abstract][Full Text] [Related]
17. The effects of a freeze-thaw cycle and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal propeptide concentrations: Implications for the detection of growth hormone misuse in athletes.
Guha N; Erotokritou-Mulligan I; Bartlett C; Cowan DA; Bassett EE; Stow M; Sönksen PH; Holt RI
Drug Test Anal; 2012 Jun; 4(6):455-9. PubMed ID: 22511534
[TBL] [Abstract][Full Text] [Related]
18. Drug testing in sport: hGH (human growth hormone).
Green GA
Virtual Mentor; 2014 Jul; 16(7):547-51. PubMed ID: 25013921
[No Abstract] [Full Text] [Related]
19. Monitoring of biological markers indicative of doping: the athlete biological passport.
Saugy M; Lundby C; Robinson N
Br J Sports Med; 2014 May; 48(10):827-32. PubMed ID: 24659506
[TBL] [Abstract][Full Text] [Related]
20. The Athlete Biological Passport: How to Personalize Anti-Doping Testing across an Athlete's Career?
Robinson N; Sottas PE; Schumacher YO
Med Sport Sci; 2017; 62():107-118. PubMed ID: 28578329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
